News

Insights into CVS Health's Recent Options Trading Patterns

Insights into CVS Health's Recent Options Trading Patterns

Understanding Current Options Trends for CVS Health

Recently, CVS Health has experienced notable movements in its options trading space. An analysis indicates a shift in market sentiment, as financial experts report a marked bearish trend surrounding CVS Health's stock, which has caught the attention of seasoned traders.

Analyzing Trader Sentiment

Diving deeper into the data, we discover that out of all observed trades, a sizable 41% of traders were bullish, while 47% exhibited bearish behaviors. Specifically, across 17 identified trades, there were 4 put options totaling approximately $440,613 and 13 call options valued at around $786,829.

Projected Price Targets for CVS

When assessing the open interest and trading volume linked to these options, it’s clear that major investors are eyeing a price range for CVS Health between $50.0 and $75.0. This price scenario has been tracked consistently over the past three months, indicating strategic positioning by institutional traders.

Options Volume and Open Interest Insights

Monitoring volume and open interest is essential for evaluating the liquidity in options trading. For CVS Health, analyzing these metrics for the last 30 days helps identify patterns in liquidity for selected strike prices ranging from $50.0 to $75.0. This knowledge will be invaluable for anyone looking to make informed decisions regarding their holdings.

Recent Activity in CVS Health Options

Noteworthy options trades have emerged in the past month, showcasing a blend of bullish and bearish strategies. Here are some significant trades that provide insight into traders' sentiments:

Highlighted Options Trades

The following options trades reveal a mix of strategies being employed by investors:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Value Open Interest Volume
CVS PUT TRADE BULLISH 10/18/24 $1.23 $1.12 $1.14 $62.00 $284.9K 607 2.5K
CVS CALL SWEEP NEUTRAL 01/16/26 $10.4 $10.1 $10.2 $60.00 $180.5K 987 178
CVS CALL TRADE BEARISH 11/15/24 $2.85 $2.37 $2.4 $65.00 $168.0K 7.3K 57
CVS PUT SWEEP BEARISH 01/16/26 $5.1 $5.0 $5.1 $55.00 $91.3K 3.7K 179
CVS CALL SWEEP BEARISH 03/21/25 $10.6 $10.5 $10.5 $55.00 $75.6K 474 73

About CVS Health

CVS Health stands out in the healthcare services sector with a diverse portfolio. Known for its reliable retail pharmacy operations, CVS manages more than 9,000 locations. Beyond retail, it acts as a major pharmacy benefit manager, processing around 2 billion claims annually, and also serves as a health insurer through its acquisition of Aetna, catering to approximately 26 million medical members. The recent acquisition of Oak Street Health enhances its primary care offerings, creating opportunities for greater integration across its services.

CVS Health's Market Performance

  • CVS Health is experiencing a trading volume of approximately 10.9 million shares, with the stock's price reflecting a modest gain of 2.06%, settling at $62.8.
  • The Relative Strength Index (RSI) suggests that the stock might be nearing overbought territory.
  • Investors are keenly awaiting an earnings announcement that is expected to take place soon.

Expert Opinions on CVS Health

Recent opinions from a panel of 4 market analysts converge on a consensus price target of $63.5 for CVS Health. This consensus reflects the collective assessment of the stock's future performance.

Understanding Options Trading Risks

Traders engaged in options may face increased risks, yet these same risks present opportunities for enhanced profits. Knowledgeable traders often reduce their exposure through continuous education, smart adjustments to their strategies, and a sharp focus on market trends. Staying informed about the latest moves in CVS Health’s options is crucial for all investors looking to navigate this dynamic market.

Frequently Asked Questions

What trends are seen in CVS Health's options trading?

Recent analysis indicates a shift towards bearish sentiment, with many traders positioning themselves for lower prices.

What is the current market price for CVS Health?

The stock is trading at approximately $62.8, reflecting recent gains in market value.

How many options trades were identified for CVS Health?

There were 17 unusual options trades detected, comprising both put and call options.

What is the significance of volume and open interest in options trading?

Volume indicates how actively options are being traded, while open interest shows the total number of outstanding contracts, both crucial for liquidity measures.

What are the recent expert ratings on CVS Health?

Experts have given a mixed bag of ratings, with a consensus target price of $63.5 among recent market analyses.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking High Performance: WorkBoard's New AI Enhancements

Updated Category News Views 101

Back in 2024, WorkBoard turned heads with its ambitious AI enhancements designed to overhaul strategy execution. You remember how organizations were struggling to keep their objectives on track? Well, that was the backdrop when WorkBoard stepped in, hoping to redefine the game. AI Capabilities: A Game Changer or Just Hype? At the Accelerate conference that year, buzz...

Continue Reading
Strengthening Leadership for Enhanced AI-Powered Aesthetics

Updated Category News Views 380

Cloud Clinic Enhances Leadership for Future Growth Cloud Clinic, an innovative healthcare technology platform, is embarking on a significant journey to expand its leadership team. This decision comes as the company aims to accelerate its growth and improve patient care across the nation. Strategic Leadership Appointments Leading the charge is John Sandberg, the visionary...

Continue Reading
HKBU Advances Wastewater Treatment with Innovative Technology

Updated Category News Views 220

Transforming Wastewater Treatment with Innovative Membranes Recent advancements by a dedicated research team from Hong Kong Baptist University (HKBU) have led to the creation of a groundbreaking catalytic membrane. This novel technology significantly enhances the effectiveness of wastewater treatment processes using advanced oxidation methods. Such innovations are crucial...

Continue Reading
CleanCore Solutions Successfully Completes Significant Funding Round

Updated Category News Views 255

CleanCore Solutions Completes Major Private Placement Today, CleanCore Solutions, Inc. (NYSE American: ZONE) announced the successful closing of a significant private investment in public equity (PIPE) financing. This funding has raised an impressive $175,000,420, a noteworthy achievement prior to deducting any agent fees or related expenses, utilizing a mix of cash and...

Continue Reading
Understanding Western Alliance Bancorporation's Legal Challenges

Updated Category News Views 181

Background on Western Alliance Bancorporation Western Alliance Bancorporation is a prominent bank holding company, primarily engaged in various banking services. Recently, the firm has come under scrutiny due to allegations concerning misleading business information exchanged with investors. This situation compels attention from current and potential investors alike,...

Continue Reading